Search - tctmd.com

Displaying 461 - 480 of 533

Sort: Relevancy | Date

News Conference News AHA 2013

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

Yael L. Maxwell

November 19, 2013

News Conference News TCT 2013

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

October 30, 2013

News Industry News

Abbott's MitraClip® Treatment Demonstrates Positive Results for Patients with Degenerative Mitral Regurgitation at Prohibitive Risk for Surgery

October 30, 2013

News Daily News

MitraClip Gains FDA Approval for Nonsurgical Patients

October 25, 2013

News Industry News

Abbott's First-In-Class MitraClip® Device Now Available for U.S. Patients

October 25, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

October 11, 2013

News Daily News

MitraClip Parece Seguro y Eficaz en Pacientes con Regurgitación No Central

L.A. McKeown

September 20, 2013

News Daily News

MitraClip Appears Safe, Effective for Patients with Noncentral Regurgitatior

L.A. McKeown

September 20, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

News Daily News

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Caitlin E. Cox

July 11, 2013

News Industry News

Novel Device May Help Stop Leaky Heart Valves

July 01, 2013

News Daily News

Risk Factors for Thrombus Formation on Cardiac Plug in A-fib Patients Identified

Yael L. Maxwell

June 28, 2013

News Daily News

Japanese Registry Finds No Mortality Benefit with CTO PCI Even When Successful

Caitlin E. Cox

June 20, 2013

News Daily News

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

June 07, 2013

News Industry News

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

June 04, 2013

News Industry News

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

May 23, 2013

News Daily News

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

May 17, 2013

News Daily News

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

May 17, 2013

Advertisement

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

Abbott's MitraClip® Treatment Demonstrates Positive Results for Patients with Degenerative Mitral Regurgitation at Prohibitive Risk for Surgery

MitraClip Gains FDA Approval for Nonsurgical Patients

Abbott's First-In-Class MitraClip® Device Now Available for U.S. Patients

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

MitraClip Parece Seguro y Eficaz en Pacientes con Regurgitación No Central

MitraClip Appears Safe, Effective for Patients with Noncentral Regurgitatior

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Novel Device May Help Stop Leaky Heart Valves

Risk Factors for Thrombus Formation on Cardiac Plug in A-fib Patients Identified

Japanese Registry Finds No Mortality Benefit with CTO PCI Even When Successful

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content